Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 5/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22199660 | 0.97 | POLB (0.49) | POLBHPGDHTTLMNASMN1; SMN2 | |
| SCHEMBL19645192 | 0.92 | POLB (0.48) | POLBHPGDHTTLMNASMN1; SMN2 | |
| SCHEMBL20340664 | 0.91 | POLB (0.47) | POLBHPGDHTTLMNASMN1; SMN2 | |
| SCHEMBL19200801 | 0.88 | L3MBTL1 (0.43) | POLBHPGDHTTLMNASMN1; SMN2 | |
| SCHEMBL20374788 | 0.87 | POLB (0.46) | POLBHPGDHTTLMNASMN1; SMN2 | |
| SCHEMBL18922367 | 0.84 | POLB (0.49) | POLBHPGDHTTLMNASMN1; SMN2 | |
| SCHEMBL19200319 | 0.81 | TSHR (0.49) | POLBHPGDHTTLMNASMN1; SMN2 | |
| SCHEMBL19182655 | 0.80 | L3MBTL1 (0.48) | POLBHPGDHTTLMNASMN1; SMN2 | |
| SCHEMBL20049915 | 0.77 | POLB (0.49) | POLBHPGDHTTLMNASMN1; SMN2 | |
| SCHEMBL19261359 | 0.77 | POLB (0.49) | POLBHPGDHTTLMNAPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210077501-A1 | COMPOSITIONS FOR PREVENTING OR TREATING UVEITIS | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2021-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210077501-A1 | COMPOSITIONS FOR PREVENTING OR TREATING UVEITIS | UACA, PDE6C, PDE6H | POLB 4676/4885HPGD 361/4885HTT 2572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.